Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-24 @ 4:02 PM
NCT ID:
NCT04444466
Brief Summary:
The purpose of the study is to assess safety, tolerability and pharmacokinetics (PK) of oral UCB8600.
Detailed Description:
The Study was only open for recruitment of Healthy Study Participants (Part A) prior to termination and did not enroll any patient population.
Study:
NCT04444466
Study Brief:
Protocol Section:
NCT04444466